News | August 12, 2025
Cohance to invest Rs. 23 crore on cGMP Oligonucleotide facility at Hyderabad
This strategic investment strengthens Cohance's integrated oligonucleotide platform
This strategic investment strengthens Cohance's integrated oligonucleotide platform
Fermenta now becomes one of the only two companies globally to hold a CEP for this variant of Vitamin D3
This certification validates the plant’s robust capabilities in manufacturing a wide range of sterile dosage forms
Changhua site meets international regulatory standards for global medical applications
First and only TROP2-directed therapy approved in the US for the treatment of lung cancer
BioNTech and Bristol Myers Squibb will jointly execute a broad clinical development program to evaluate and advance BNT327 across numerous solid tumor types
Adds fast-growing and only approved medicine for advanced and indolent systemic mastocytosis to the Sanofi portfolio
This global affiliation marks a critical step in the company’s mission to create long-term value through ethical practices, scientific innovation, and inclusive healthcare delivery
The CEP certification for Metformin Hydrochloride aligns with the company's strategy to penetrate stringently regulated markets
This significant milestone enhances our global regulatory standing
Subscribe To Our Newsletter & Stay Updated
